Rebalancing Pharmaceutical Pricing Without Sacrificing Innovation

Two weeks ago, President Trump sent letters to 17 leading pharmaceutical manufacturers, giving them 60 days to propose plans to lower U.S. drug prices to align with the lowest prices offered in other developed nations.

This is an opportunity to recalibrate pharmaceutical pricing in a way that brings relief to U.S. consumers, corrects global imbalances…